The market for graft versus host disease (GvHD) prophylaxis and treatment in the five growth markets (5GM*) in the Asia-...
As analytics continues to guide and drive the world’s response to COVID-19, SAS debuts the final instalment of its...
Following the announcement that Renalytix AI’s KidneyIntelX™ platform will be used to assess the risk o...
Ventilator shortages are a critical reality as the COVID-19 outbreak continues to worsen globally. According to GlobalDa...
There is currently 445 chimeric antigen receptor (CAR-T cell) therapies under development by companies headquartered acr...
The Duterte administration is implementing a three-pronged strategy to mitigate the social and economic impact of t...
The pneumococcal vaccines market is expected to grow from $5.11bn in 2018 to $6.24bn in 2028 across ...
The impact of the COVID-19 pandemic on the global economy has business leaders in an unprecedented state of uncertainty....
The axial spondyloarthritis (axSpA) market across the five growth markets (5GM*) in the Asia-Pacific (APAC) region will ...
In an era where the healthcare industry is moving toward personalized care solutions and the acknowledgment of inherent ...
Digital marketing in pharma is gaining increasing importance in recent times and Indian multinational pharmaceutical com...
ConvaTec Group Plc is putting the Asia Pacific region, along with Latin America, The Middle East and Africa, at the fore...
Following the recent official gazette notification from the Ministry of Health & Family Welfare (MOHFW) of India tha...
Expectations for biosimilars are high in 2020, and the drug class will finally begin to make its mark in the US, says Gl...
Malaysia’s aspiration to push HealthTech to the forefront will provide myriad opportunities to innovative domestic...
Readers of GlobalData’s Pharmaceutical Technology have been voting for whether Britain’s exit from the EU an...
Galen Growth, the leading HealthTech intelligence, analytics and advisory firm serving Fortune 500 companies and global ...
The spinal muscular atrophy (SMA) market across the five growth markets ((5GM) Australia, China, India, Japan and South ...
